135 Matching Annotations
  1. Last 7 days
  2. Aug 2026
  3. Jun 2026
  4. May 2026
  5. Apr 2026
  6. Mar 2026
  7. Feb 2026
  8. Jan 2026
  9. Dec 2025
  10. Nov 2025
  11. Oct 2025
  12. Sep 2025
  13. May 2025
  14. Mar 2025
  15. Feb 2025
  16. Dec 2024
  17. Oct 2024
  18. Sep 2024
  19. Aug 2024
  20. Jul 2024
  21. Apr 2024
  22. Mar 2024
  23. Jan 2024
  24. Dec 2023
  25. Oct 2023
  26. Sep 2023
  27. Aug 2023
  28. Jul 2023
  29. Mar 2023
  30. Feb 2023
  31. Jan 2023
  32. Nov 2022
  33. Oct 2022
  34. Aug 2022
  35. Jun 2022
  36. May 2022
  37. Apr 2022
  38. Mar 2022
  39. Feb 2022
  40. Jan 2022
  41. Dec 2021
  42. Nov 2021
  43. Oct 2021
  44. Sep 2021
  45. Aug 2021
  46. Jul 2021
  47. Jun 2021
  48. May 2021
  49. Apr 2021
  50. Mar 2021
  51. Feb 2021
  52. Nov 2020
  53. Oct 2020
  54. Sep 2020
  55. Jan 2020
  56. Nov 2018
  57. Nov 2017
    1. Before adding the fluorescently labeled antibodies, Fc-receptors were blocked with anti-CD16/CD32 (Pharmingen) antibodies was performed. Mammary epithelial cells were labeled with antibodies directed against CD24 (Pharmingen #553261), CD49f (Pharmingen #551129) and CD61 (eBioscience #11-0622-82). Non-epithelial cells were excluded using antibodies directed against CD45 (BD #553078), CD31 (BioLegend #102404) and Ter119 (BioLegend #116204)

      Curator: @bandrow

      Curator note: BioLegend Cat# 116204, RRID:AB_313705

      Resource used:

      (BioLegend Cat# 116204, RRID:AB_313705)

      SciCrunch record: RRID:AB_313705

      Alternate resolvers: SciCrunch xml N2T identifiers.org


      What is this?